Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and Safety of Synbiotics in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Randomized, Double-blinded, Placebo-controlled Pilot Study.
Mizutani Y, Kawamoto S, Takahashi M, Doi H, Wakida K, Tabuchi S, Tanda M, Soga A, Chijiki R, Takakura H, Kawaguchi K, Higashime A, Watanabe M, Ichikawa H, Matsumoto S, Sakai R, Goto H, Kurata K, Kakiuchi S, Miyata Y, Uryu K, Inui Y, Kitao A, Yakushijin K, Matsuoka H, Minami H. Mizutani Y, et al. Among authors: uryu k. Intern Med. 2023 Oct 15;62(20):2949-2958. doi: 10.2169/internalmedicine.1314-22. Epub 2023 Feb 15. Intern Med. 2023. PMID: 36792187 Free PMC article. Clinical Trial.
Antibody responses to SARS-CoV-2 nucleocapsid and spike proteins in hospitalized patients with COVID-19: A multicenter, retrospective, cross-sectional study in Japan.
Hibino M, Watanabe S, Tobe S, Maeda K, Horiuchi S, Nishiguchi S, Iwase A, Uryu K, Kobayashi S, Kondo T. Hibino M, et al. Among authors: uryu k. Respir Investig. 2022 Mar;60(2):256-263. doi: 10.1016/j.resinv.2021.11.006. Epub 2021 Dec 3. Respir Investig. 2022. PMID: 34924308 Free PMC article.
Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M-Positive Non-Small-Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II Trial.
Nakao A, Hiranuma O, Uchino J, Sakaguchi C, Kita T, Hiraoka N, Ishizuka T, Kubota Y, Kawasaki M, Goto Y, Imai H, Hattori N, Nakatomi K, Uramoto H, Uryu K, Fukuda M, Uchida Y, Yokoyama T, Akai M, Mio T, Nagashima S, Chihara Y, Tamiya N, Kaneko Y, Mouri T, Yamada T, Yoshimura K, Fujita M, Takayama K. Nakao A, et al. Among authors: uryu k. Oncologist. 2019 May;24(5):593-e170. doi: 10.1634/theoncologist.2019-0003. Epub 2019 Jan 16. Oncologist. 2019. PMID: 30651400 Free PMC article. Clinical Trial.
[Loss of CD45 expression at relapse of acute myeloid leukemia].
Yamamoto K, Yakushijin K, Kurata K, Mizutani Y, Inui Y, Uryu K, Kawamoto S, Sugimoto T, Matsuoka H, Minami H. Yamamoto K, et al. Among authors: uryu k. Rinsho Ketsueki. 2017;58(8):938-941. doi: 10.11406/rinketsu.58.938. Rinsho Ketsueki. 2017. PMID: 28883278 Japanese.
Early lymphocyte recovery predicts clinical outcome after HSCT with mycophenolate mofetil prophylaxis in the Japanese population.
Kurata K, Yakushijin K, Mizuno I, Gomyo H, Okamura A, Ichikawa H, Sakai R, Mizutani Y, Kakiuchi S, Miyata Y, Kitao A, Sanada Y, Inui Y, Uryu K, Kawamoto S, Sugimoto T, Yamamoto K, Ito M, Matsuoka H, Murayama T, Minami H. Kurata K, et al. Among authors: uryu k. Int J Hematol. 2018 Jul;108(1):58-65. doi: 10.1007/s12185-018-2437-z. Epub 2018 Mar 22. Int J Hematol. 2018. PMID: 29569120
Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Inui Y, Yakushijin K, Okamura A, Tanaka Y, Shinzato I, Nomura T, Ichikawa H, Mizutani Y, Kitao A, Kurata K, Kakiuchi S, Miyata Y, Sanada Y, Kitagawa K, Uryu K, Kawamoto S, Yamamoto K, Matsuoka H, Murayama T, Ito M, Minami H. Inui Y, et al. Among authors: uryu k. Transpl Infect Dis. 2019 Feb;21(1):e13024. doi: 10.1111/tid.13024. Epub 2018 Nov 27. Transpl Infect Dis. 2019. PMID: 30414316
145 results